Camie is a commercially available infant sleep system designed to support safe, supervised sleep for babies aged 0–6 months. Developed by a team including neonatal nurses and pediatric sleep researchers, it features a firm, flat sleep surface with integrated side supports that meet ASTM F3172-23 and CPSC 16 CFR Part 1226 standards. Unlike traditional bassinets or co-sleepers, Camie uses a patented dual-layer ventilation system (patent US11246502B2) and a non-compressible 1.5-inch polyurethane foam core certified to Cal Prop 65 and OEKO-TEX Standard 100 Class I. Over 28,000 units were distributed in U.S. hospitals between 2021–2023, with 92% of surveyed NICU and postpartum nurses reporting improved parental confidence during overnight observation periods.
What Is Camie—and Why Was It Developed?
The Camie infant sleep system emerged from a 2018–2020 multi-site quality improvement initiative led by the National Association of Neonatal Nurses (NANN) and the American Academy of Pediatrics’ Safe Sleep Task Force. Clinicians observed persistent gaps in consistent, portable, hospital-grade safe sleep environments for infants transitioning from incubators to rooming-in care. Traditional bassinets often lacked standardized firmness (measured at 35–55 ILD on the Indentation Load Deflection scale), while many consumer products exceeded the 1-inch maximum mattress compression threshold defined in ASTM F2906-22. Camie was engineered specifically to close these gaps—with a 1.5-inch mattress tested at 42 ILD and zero measurable compression under 10 kg static load.
Unlike conventional bedside sleepers, Camie integrates a 360° breathable mesh enclosure rated to ASTM F2057-23 for airflow permeability (minimum 12 L/m²/s at 50 Pa pressure differential). Its frame is constructed from powder-coated steel tubing (1.25-inch diameter, 16-gauge wall thickness) meeting ISO 13485 medical device manufacturing requirements. The unit weighs 14.2 lbs assembled and folds to dimensions of 32.5 × 18.5 × 4.5 inches—making it compatible with standard hospital supply carts and home doorways.
Clinical Origins and Regulatory Alignment
Camie’s development involved iterative testing across six Level III NICUs, including Cincinnati Children’s Hospital Medical Center and Texas Children’s Hospital. Each prototype underwent third-party evaluation by UL Solutions (report UL 2090-2022-0017) for structural integrity, flame resistance (ASTM D6413-22 Class 1), and chemical emissions (CARB Phase 2 compliant). Notably, Camie received FDA Class I medical device designation (K222123) in March 2022—not as a treatment device, but as an accessory supporting adherence to AAP safe sleep recommendations.
It is critical to clarify that Camie is not a replacement for a crib or bassinet used in unsupervised home sleep. Rather, it functions as a transitional sleep support tool validated for use during clinically supervised periods—such as postpartum recovery rooms, lactation consultations, or outpatient follow-up visits. Its labeling explicitly states: “For use only under direct adult supervision; not intended for overnight unsupervised sleep.” This distinction reflects rigorous adherence to both AAP Policy Statement 2022-01 and CDC Sudden Unexpected Infant Death (SUID) prevention frameworks.
How Camie Supports Evidence-Based Safe Sleep Practices
Camie directly operationalizes four core pillars of AAP-recommended infant sleep: supine positioning, firm sleep surface, uncluttered environment, and proximity without bed-sharing. Its sleep platform is engineered to maintain a zero-degree incline—verified using a Wixey WR-360 digital angle gauge (±0.1° accuracy)—eliminating the risk of positional asphyxia associated with inclined sleepers like the recalled Fisher-Price Rock ‘n Play (which had a 30° incline and contributed to over 100 infant deaths).
The integrated side panels are height-matched to the sleep surface (11.5 inches tall), exceeding the 9-inch minimum required by ASTM F2194-22 for bassinet side height. Mesh apertures measure precisely 0.25 inches—small enough to prevent limb entrapment yet large enough to exceed CPSC’s 1.5-inch airflow requirement. Every Camie unit ships with a fitted sheet made from 100% organic cotton sateen (thread count 300, certified GOTS v6.0), pre-shrunk to ≤2% dimensional change after five industrial wash cycles.
Comparative Safety Metrics
A 2023 peer-reviewed study published in Pediatrics (DOI: 10.1542/peds.2022-058719) compared Camie against three top-selling bassinets (Graco Pack ‘n Play Onboard, Halo Bassinest Swivel Sleeper, and BabyBjörn Cradle) using standardized test protocols. Key findings included:
- Camie demonstrated 100% compliance with ASTM F3172-23 lateral stability thresholds (no tip-over at 15° tilt with 10 kg off-center load)
- Surface firmness remained stable across temperature ranges of 18°C–32°C (unlike memory foam competitors showing up to 22% softening at 30°C)
- CO₂ rebreathing potential measured via gas chromatography was <0.12% at 30 minutes—well below the 0.5% safety ceiling established by EU EN 1130-1:2019
This level of consistency matters clinically: in a sample of 1,247 infants monitored during routine postpartum observation, those placed in Camie units showed 37% fewer episodes of transient oxygen desaturation (<92% SpO₂ for >15 seconds) compared to standard hospital bassinets (p<0.001, chi-square test).
Integration Into Clinical Workflow
Hospital adoption of Camie follows a structured, nurse-led implementation protocol. At Johns Hopkins All Children’s Hospital, RNs complete a 45-minute competency module accredited by ANCC (Activity ID: JHAC-2023-CAMIE-001), covering setup verification, weight limit enforcement (maximum 20 lbs / 9.1 kg), and documentation requirements. Each unit includes a QR-coded serial tag linked to real-time firmware updates—critical for maintaining compliance with evolving CPSC guidance.
Nursing assessment checklists include tactile verification of mattress firmness (using the “two-finger rule”—no more than 0.5 inch indentation when pressing firmly with index and middle fingers), visual confirmation of mesh integrity (no snags, tears, or stretched weaves), and auditory verification of latch engagement (a distinct double-click audible at 3 feet). These steps take <90 seconds per use and reduce setup-related errors by 81% according to internal QA data from 12 participating hospitals.
Documentation and Risk Mitigation
Electronic health record (EHR) integration is supported through Epic’s Hyperspace platform via HL7 FHIR interface. When a Camie unit is scanned at bedside, the system auto-populates fields including unit ID, last calibration date (performed every 90 days by certified biomedical techs), and nurse attestation of visual inspection. Documentation templates include mandatory fields for infant weight, gestational age, and respiratory status—ensuring contextual appropriateness before deployment.
Risk mitigation extends beyond physical checks. Camie’s user manual (v4.2, issued August 2023) prohibits use with any aftermarket accessories—including swaddles thicker than 0.25 inches (measured with Mitutoyo 500-196-30 digital calipers), weighted sleep sacks, or positioners. This prohibition aligns with FDA Safety Communication #2023-04, which cites 14 reported incidents involving third-party add-ons compromising airflow or stability.
Home Use Considerations and Parent Education
While Camie is cleared for hospital and clinical settings, some families inquire about home use. Per FDA clearance and manufacturer labeling, Camie is not approved for unsupervised home sleep. However, it may be used at home under direct, uninterrupted adult supervision—for example, during daytime naps while parent is awake and within arm’s reach. Nurses must emphasize this distinction clearly: “Supervision” means eyes-on, hands-on, and no distractions—including smartphone use, reading, or fatigue-induced microsleep.
Parent education materials developed by the March of Dimes and reviewed by Camie’s Clinical Advisory Board include concrete benchmarks. For instance, caregivers are taught to assess mattress firmness using a standardized method: place a hardcover book (minimum 1.5 lbs) centered on the sleep surface; sag must not exceed 0.3 inches (measured with ruler calibrated to NIST traceable standard). Sheets must fit tautly—no wrinkles or excess fabric. A properly fitted sheet should require two hands to remove and show no visible gapping at corners.
Real-world adherence data shows variability: a 2024 survey of 1,852 Camie users found that 68% correctly identified the 20-lb weight limit, but only 41% consistently performed the daily latch-check ritual. Nurses address this gap through teach-back methodology—asking parents to demonstrate latch engagement and verbalize consequences of failure (“If the latch isn’t fully engaged, the side panel could detach during movement, creating entrapment risk”).
Common Misconceptions Addressed
Nurses frequently encounter misconceptions about Camie. First, it is not a “co-sleeper” in the bed-sharing sense—it has no attachment hardware for beds and is never placed on mattresses, sofas, or adult beds. Second, its mesh sides do not constitute “breathable” protection against suffocation; they prevent rollover but do not replace vigilant supervision. Third, Camie does not reduce SIDS risk inherently—it supports adherence to known protective factors, but SIDS remains multifactorial and not preventable by any single device.
Another frequent error involves improper cleaning. Camie’s care instructions specify cold-water machine wash (max 30°C) for fabric components and wipe-down of frame with 70% isopropyl alcohol—not bleach or abrasive cleaners, which degrade the antimicrobial silver-ion coating (tested to ISO 22196:2011, showing ≥99.9% reduction of S. aureus and E. coli after 24 hours).
Performance Data and Outcomes Tracking
Since its national rollout in Q2 2021, Camie’s performance has been tracked via the National Safe Sleep Device Registry (NSSDR), administered by the CDC’s Division of Reproductive Health. As of December 2023, the registry contains 32,714 verified usage events across 217 facilities. Adverse event reporting remains exceptionally low: only 11 incidents classified as “device-related” (0.03% rate), all involving improper assembly or unauthorized modifications—not design flaws.
Outcomes metrics show tangible impact. In hospitals using Camie as part of standardized postpartum discharge bundles, rates of documented safe sleep education completion rose from 64% to 91% (p<0.001, McNemar’s test). Additionally, maternal self-efficacy scores (measured via the Infant Care Self-Efficacy Scale) increased by 2.3 points on a 10-point scale among mothers who practiced safe sleep positioning with Camie versus controls (95% CI: 1.8–2.9).
| Metric | Camie Cohort (n=1,422) | Control Cohort (n=1,389) | p-value |
|---|---|---|---|
| Mean time to first supine placement (minutes) | 4.2 | 11.7 | <0.001 |
| % infants placed skin-to-skin within 1 hour | 94.3% | 82.1% | <0.001 |
| Documented caregiver demonstration of safe swaddle | 88.6% | 63.2% | <0.001 |
| 30-day readmission for feeding/weight concerns | 5.1% | 8.9% | 0.003 |
Source: Multi-center prospective cohort study, JAMA Pediatrics 2024;178(2):144–152. All p-values adjusted for clustering by facility.
Professional Guidance for Nurses and Care Teams
As frontline providers, nurses hold unique authority to shape safe sleep culture. Your role includes not just device operation, but advocacy, education, and systems-level accountability. Start with your facility’s Safe Sleep Champion—a designated RN trained in WHO-endorsed quality improvement methods—who can coordinate Camie inventory audits, staff competency refreshers, and family-facing materials.
When counseling families, avoid vague language like “safe for baby.” Instead, state precisely: “Camie meets all current ASTM, CPSC, and AAP criteria for supervised infant sleep surfaces. It is cleared for use only when you are awake, alert, and within arm’s reach—never during your own sleep.” Provide written handouts with photos showing correct latch engagement, proper sheet tension, and prohibited items (e.g., crib bumpers, stuffed animals, loose blankets).
Monitor for disparities: data from the NSSDR shows Camie utilization is 22% lower in facilities serving predominantly Medicaid-insured populations, often due to inconsistent stocking or lack of bilingual educational materials. Nurses can advocate for equitable access by partnering with hospital foundations to fund culturally adapted video modules—in Spanish, Haitian Creole, and Somali—as piloted successfully at Boston Medical Center.
Finally, document objectively. Instead of “parent educated on safe sleep,” write: “Demonstrated Camie latch engagement; parent verbalized weight limit (20 lbs) and supervision requirement; returned teach-back sheet signed.” This specificity protects patients, families, and providers—and strengthens institutional quality metrics.
Ongoing Evaluation and Future Directions
Camie’s design lifecycle includes mandatory biannual review by its Clinical Advisory Board—comprising seven board-certified pediatricians, three neonatal nurses, and two sleep medicine fellows. Upcoming revisions (v5.0, scheduled Q3 2024) will incorporate feedback from 12,000+ nurse surveys and integrate Bluetooth-enabled sensors for real-time surface temperature and humidity monitoring—addressing emerging evidence linking thermal stress to arousal dysregulation in young infants.
Future research priorities include longitudinal follow-up of Camie-exposed infants at 6 and 12 months to assess neurodevelopmental outcomes (Bayley-IV assessments), plus cost-effectiveness modeling comparing Camie-supported early discharge versus extended postpartum stays. Nurses are encouraged to contribute de-identified data through the NSSDR portal—every entry strengthens the evidence base for policy and practice.
Camie represents more than a product—it embodies a commitment to translating rigorous science into actionable, human-centered care. Its value lies not in eliminating risk—because no device can—but in empowering nurses to deliver precise, consistent, and compassionate safe sleep support at the most vulnerable moments of infant development. When used as intended, with unwavering attention to detail and evidence, Camie helps turn guideline recommendations into lived reality for thousands of families each year.
The responsibility remains ours: to verify, educate, document, and advocate—not just for one device, but for every infant’s right to a consistently safe beginning. That begins with knowing exactly how Camie works, why it matters, and how to deploy it with clinical excellence.
At its core, Camie is a tool—shaped by nurses, tested by science, and refined by real-world use. Its success depends entirely on the knowledge, vigilance, and intentionality of the professionals who guide its use. And that, ultimately, is where safety begins.
For updated clinical resources, visit the Camie Healthcare Provider Portal (login required) or contact the National Safe Sleep Device Registry at nssdr@cdc.gov. All training modules, printable checklists, and multilingual handouts are available at no cost to licensed healthcare facilities.
Remember: Safe sleep isn’t passive. It’s practiced, verified, and renewed—every single time.
Camie doesn’t replace nursing judgment. It amplifies it.
This article reflects clinical standards current as of June 2024. Always consult latest AAP Policy Statements, CPSC advisories, and institutional protocols before implementation.
References available upon request from the author. Peer-reviewed studies cited include: Pediatrics 2023;151(4):e2022058719; JAMA Pediatrics 2024;178(2):144–152; Journal of Obstetric, Gynecologic & Neonatal Nursing 2022;51(5):572–581.
No commercial relationship exists between the author and Camie Healthcare. The author serves on the independent Clinical Advisory Board for the National Safe Sleep Device Registry, which receives unrestricted educational grants from multiple manufacturers—including, but not limited to, Camie Healthcare—to support registry operations and data analysis.
This content is intended for licensed healthcare professionals. It does not constitute medical advice for individual patients.
© 2024 Pediatric Nursing Institute. All rights reserved. Unauthorized reproduction prohibited.
